Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
Dr. Dereck Mush, MD, MBA
Valo Health
Integrates human data and machine learning to accelerate therapeutic discovery.
What they do
Valo Health developed the Opal Platform, an end to end proprietary operating system designed to streamline drug discovery and development. By using human centric data and machine learning, they help drug developers minimize risk and speed up clinical trial timelines.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2019
- Total funding
- $439M raised
Notable investors: Koch Disruptive Technologies, Flagship Pioneering, Fidelity Management, PSP Investments.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Dr. Dereck Mush, MD, MBA
AI is moving upstream, from molecule design into disease target identification itself
Dr. Dereck Mush, MD, MBA